Bieżący suplement Archiwum Klinika Oczna |
3/2004
vol. 106 streszczenie artykułu:
Artykuł oryginalny
Jod w leczeniu zwyrodnienia ciała szklistego
Krystyna Raczyńska
1
,
Witold Kokot
1
,
Jarosława Krajka-Lauer
1
,
Barbara Iwaszkiewicz-Bilikiewicz
1
KLINIKA OCZNA 2004, Supl. 3: S517–S520
Data publikacji online: 2022/12/29
Pełna treść artykułu
Pobierz cytowanie
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Purpose We present our result of topical administration of iodine in group of patients with corpus vitreous degeneration. Material and methods Corpus vitreous degeneration was studied in 360 patients (660 eyes), 184 male and 176 female. Treatment last form 6 to 12 month. We administrate iodine 3-4 times a day as an eye drops. The untreated control group consist of 110 person (204 eyes) 80 male and 50 female with similar corpus vitreous degeneration. Results The results are discussed in relation to our own vitreous degeneration scale. We come to a conclusion that topical administration of iodine reduce corpus vitreous degeneration. |